Wang et al. apply INVADEseq to probe intracellular bacteria in oral squamous cell carcinoma patients treated with neoadjuvant immunotherapy. They show that bacteria modulate immune efficacy, identify specific response predictors, and uncover the impact of bacteria on the communication between predictors and cDC1s.